Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Invion ( (AU:IVX) ) has issued an update.
Invion Limited has announced a change in the interests of its director, Chiat Thian Chew, involving the lapse and cancellation of 1,384,886 unlisted options without conversion. This adjustment in the director’s securities holdings reflects a strategic decision that may impact the company’s governance and shareholder dynamics.
More about Invion
Invion Limited operates in the biotechnology industry, focusing on the development of treatments for chronic inflammatory diseases. The company is involved in the research and commercialization of pharmaceutical products.
Average Trading Volume: 120,749
Technical Sentiment Signal: Sell
Current Market Cap: A$10.28M
For an in-depth examination of IVX stock, go to TipRanks’ Overview page.